The outcome of this study could significantly impact Sanofi’s stock performance and investor sentiment, as successful results may position Teplizumab as a leading treatment for Type 1 Diabetes. This ...

Breakthrough T1D International, the leading global type 1 diabetes (T1D) research and advocacy organization, in partnership ...

Objectives To estimate the prevalence of established atherosclerotic cardiovascular disease (eASCVD) and the prevalence of ...

August 01, 2025 - The increasing prevalence of chronic and genetic diseases is a major factor driving revenue growth in the gene expression analysis ...

As the federal Liberals consider a path forward for a national pharmacare plan, one advocacy group is calling on the ...

Home to almost 1·3 billion people (16% of the world's population; 55% under the age of 20 years), sub-Saharan Africa is a ...

Hybrid closed-loop systems were associated with improved glycemic control and safety during prolonged daytime fasting in type 1 diabetes.